Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Randomized, Participant- and Investigator Blind, Double Dummy, Placebo- and Comparator-controlled, Single Ascending Dose and Parallel-group Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Different Modes of (S) Ketamine Administration in Healthy Participants


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03808259

Organisation Name: Janssen Research & Development, LLC

Overal Status: Completed

Start Date: December 20, 2018

Last Update: September 12, 2019

Lead Sponsor: Janssen Research & Development, LLC

Brief Summary: The purpose of this study is to determine the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of different modes of (S) ketamine administration in healthy participants.

Conditions:
  • Healthy


Total execution time in seconds: 0.1605761051178